Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel ...
SAN FRANCISCO, CA / ACCESS Newswire / February 18, 2025 / Jaguar Health, Inc. ( NASDAQ:JAGX) ("Jaguar" or the "Company") and Jaguar family company Napo Pharmaceuticals ("Napo") today announced ...
Will that prove to be a disaster? It's right there alongside brands like Levi's or Nike – Jaguar flirts with Lady Death in more ways than we or they can imagine. In their quest for social media ...